Chugai Pharmaceutical (CHGCY) Insider Trading & Ownership $23.09 -0.12 (-0.52%) As of 03/28/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock There is no recent insider trading on record for Chugai Pharmaceutical, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public. Get CHGCY Insider Trade Alerts Want to know when executives and insiders are buying or selling Chugai Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Remove Ads Chugai Pharmaceutical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction6/21/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$16.06$1,001 - $15,0004/4/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$18.15$1,001 - $15,0008/18/2023Josh GottheimerU.S. Congress Member (D-NJ)Buy$14.51$1,001 - $15,0007/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$13.55$1,001 - $15,0003/31/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$12.29$15,001 - $50,0002/27/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Buy$12.55$1,001 - $15,000 (Data available from 1/1/2013 forward) CHGCY Insider Trading Activity - Frequently Asked Questions Which members of congress are trading Chugai Pharmaceutical? Josh Gottheimer (D-NJ) has sold shares of Chugai Pharmaceutical in the last year totaling $16,000. Chugai Pharmaceutical Key ExecutivesDr. Osamu Okuda (Age 61)President, CEO & Chairman Compensation: $1.69MMr. Iwaaki Taniguchi (Age 57)Executive VP, Head of Finance Supervisory Division, CFO & Director Toshiya SasaiExecutive of Investor Relations Group & Corporate Communications DepartmentMr. Masayoshi HiguchiVP and Head of Quality, Regulatory Compliance Unit, Business Strategy & Compliance Dept.Junichi TakanoHead of Marketing & Sales DivisionMr. Shinji HidakaExecutive Vice PresidentMr. Junichi EbiharaExecutive Vice PresidentDr. Yoshiaki Ohashi (Age 64)Senior VP & Full-time Audit Supervisory Board Member Mr. Tetsuya YamaguchiExecutive VP & Head of PHC Solution UnitMr. Yoshiyuki YanoExecutive Vice President More Insider Trading Tools from MarketBeat Related Companies McKesson Insider Selling Cencora Insider Selling Cardinal Health Insider Selling Herbalife Insider Selling Nu Skin Enterprises Insider Selling Cosmos Health Insider Selling HWH International Insider Selling TRxADE HEALTH Insider Selling Roche Insider Selling AstraZeneca Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (OTCMKTS:CHGCY) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chugai Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chugai Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
